Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 189

Similar articles for PubMed (Select 21614565)

1.

Increased risk for distant metastasis in patients with familial early-stage breast cancer and high EZH2 expression.

Alford SH, Toy K, Merajver SD, Kleer CG.

Breast Cancer Res Treat. 2012 Apr;132(2):429-37. doi: 10.1007/s10549-011-1591-2. Epub 2011 May 26.

2.

Investigations for patients with early-stage breast cancer: oversetting the stage.

Rayson D, Porter G.

CMAJ. 2015 Jun 22. pii: cmaj.150621. [Epub ahead of print] No abstract available.

PMID:
26100842
3.

Erratum to: Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.

Fouad TM, Kogawa T, Liu DD, Shen Y, Masuda H, El-Zein R, Woodward WA, Chavez-MacGregor M, Alvarez RH, Arun B, Lucci A, Krishnamurthy S, Babiera G, Buchholz TA, Valero V, Ueno NT.

Breast Cancer Res Treat. 2015 Jul;152(2):417. doi: 10.1007/s10549-015-3477-1. No abstract available.

PMID:
26092296
4.

High RAD54B expression: an independent predictor of postoperative distant recurrence in colorectal cancer patients.

Nagai Y, Yamamoto Y, Yasuhara T, Hata K, Nishikawa T, Tanaka T, Tanaka J, Kiyomatsu T, Kawai K, Nozawa H, Kazama S, Yamaguchi H, Ishihara S, Sunami E, Yamanaka T, Miyagawa K, Watanabe T.

Oncotarget. 2015 May 20. [Epub ahead of print]

5.

Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis.

Fouad TM, Kogawa T, Liu DD, Shen Y, Masuda H, El-Zein R, Woodward WA, Chavez-MacGregor M, Alvarez RH, Arun B, Lucci A, Krishnamurthy S, Babiera G, Buchholz TA, Valero V, Ueno NT.

Breast Cancer Res Treat. 2015 Jul;152(2):407-16. doi: 10.1007/s10549-015-3436-x. Epub 2015 May 29.

PMID:
26017070
7.

Serial monitoring of circulating tumor DNA in patients with primary breast cancer for detection of occult metastatic disease.

Olsson E, Winter C, George A, Chen Y, Howlin J, Tang MH, Dahlgren M, Schulz R, Grabau D, van Westen D, Fernö M, Ingvar C, Rose C, Bendahl PO, Rydén L, Borg Å, Gruvberger-Saal SK, Jernström H, Saal LH.

EMBO Mol Med. 2015 May 18. pii: e201404913. doi: 10.15252/emmm.201404913. [Epub ahead of print]

8.

Have We Given Up on Breast Cancer Metastasis? Global Trends in Breast Cancer Metastasis Research Productivity.

Ha R, Chow D, Mango V, Friedlander L, Desperito E, Wynn R.

Breast J. 2015 Jul;21(4):442-4. doi: 10.1111/tbj.12436. Epub 2015 May 18. No abstract available.

PMID:
25982155
9.

Enhancer of zeste homolog 2 as an independent prognostic marker for cancer: a meta-analysis.

Chen S, Huang L, Sun K, Wu D, Li M, Li M, Zhong B, Chen M, Zhang S.

PLoS One. 2015 May 14;10(5):e0125480. doi: 10.1371/journal.pone.0125480. eCollection 2015.

10.

SEMA6D Expression and Patient Survival in Breast Invasive Carcinoma.

Chen D, Li Y, Wang L, Jiao K.

Int J Breast Cancer. 2015;2015:539721. doi: 10.1155/2015/539721. Epub 2015 Apr 20.

11.

Overexpression of YB1 and EZH2 are associated with cancer metastasis and poor prognosis in renal cell carcinomas.

Wang Y, Chen Y, Geng H, Qi C, Liu Y, Yue D.

Tumour Biol. 2015 Apr 17. [Epub ahead of print]

PMID:
25877750
12.

Gray-Level Co-Occurrence Matrix Texture Analysis of Breast Tumor Images in Prognosis of Distant Metastasis Risk.

Vujasinovic T, Pribic J, Kanjer K, Milosevic NT, Tomasevic Z, Milovanovic Z, Nikolic-Vukosavljevic D, Radulovic M.

Microsc Microanal. 2015 Apr 10:1-9. [Epub ahead of print]

PMID:
25857827
13.

Clinicopathological significance of dual-specificity protein phosphatase 4 expression in invasive ductal carcinoma of the breast.

Kim H, Jang SM, Ahn H, Sim J, Yi K, Chung Y, Han H, Rehman A, Chung MS, Jang K, Paik SS.

J Breast Cancer. 2015 Mar;18(1):1-7. doi: 10.4048/jbc.2015.18.1.1. Epub 2015 Mar 27.

14.

S100 protein in breast tumor.

Li F, Men X, Zhang W.

Indian J Cancer. 2014 Mar;51 Suppl 3:e67-71. doi: 10.4103/0019-509X.154046.

15.

Prospective validation of DACH2 as a novel biomarker for prediction of metastasis and prognosis in muscle-invasive urothelial carcinoma of the bladder.

He YD, Luo ZH, Yang M, Ruan XX, Liu SY, Wu ZQ, Deng WM, Shao CK, Su ZL, He D, Gao X, Li LY.

Biochem Biophys Res Commun. 2015 Apr 10;459(3):416-23. doi: 10.1016/j.bbrc.2015.02.119. Epub 2015 Mar 2.

PMID:
25744029
16.

Cancer Stem Cell Markers in Eyelid Sebaceous Gland Carcinoma: High Expression of ALDH1, CD133, and ABCG2 Correlates With Poor Prognosis.

Kim N, Choung HK, Lee MJ, Khwarg SI, Kim JE.

Invest Ophthalmol Vis Sci. 2015 Feb 24;56(3):1813-9. doi: 10.1167/iovs.14-15547.

PMID:
25711631
17.

Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkers.

Ip JC, Pang TC, Glover AR, Soon P, Zhao JT, Clarke S, Robinson BG, Gill AJ, Sidhu SB.

Oncologist. 2015 Mar;20(3):247-56. doi: 10.1634/theoncologist.2014-0392. Epub 2015 Feb 5.

PMID:
25657202
18.

The plasma DNA concentration as a potential breast cancer screening marker.

Tangvarasittichai O, Jaiwang W, Tangvarasittichai S.

Indian J Clin Biochem. 2015 Jan;30(1):55-8. doi: 10.1007/s12291-013-0407-z. Epub 2013 Nov 22.

PMID:
25646041
19.

[Expression of enhancer of zeste homolog 2 in esophageal squamous cell carcinoma and its prognostic value in postoperative patients].

Wang HR, Wang MH, Lian GY, Wu DG.

Nan Fang Yi Ke Da Xue Xue Bao. 2015 Jan;35(1):99-102. Chinese.

20.

Expression of proliferation markers Ki67, cyclin A, geminin and aurora-kinase A in primary breast carcinomas and corresponding distant metastases.

Tökés AM, Szász AM, Geszti F, Lukács LV, Kenessey I, Turányi E, Meggyesházi N, Molnár IA, Fillinger J, Soltész I, Bálint K, Hanzély Z, Arató G, Szendröi M, Kulka J.

J Clin Pathol. 2015 Apr;68(4):274-82. doi: 10.1136/jclinpath-2014-202607. Epub 2015 Jan 16.

PMID:
25595275
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk